CIK 0001427925 · Non-accelerated filer<br>Smaller reporting company
TALPHERA, INC.
Sign in to watch- Ticker
- TLPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 412193603
- Phone
- 650-216-3500
- Business address
- 1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA, 94404
- Former names
- ACELRX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-15 | Broadfoot Jill Marie Director | Grant or award | +15,500 | 30,500 | ||
| 2022-07-15 | Broadfoot Jill Marie Director | Grant or award · Stock Option (Right to Buy) | +31,000 | 31,000 | ||
| 2022-07-15 | Bozilenko Marina Director | Grant or award | +15,500 | 40,500 | ||
| 2022-07-15 | Bozilenko Marina Director | Grant or award · Stock Option (Right to Buy) | +31,000 | 31,000 | ||
| 2022-07-15 | Afable Richard Director | Grant or award | +15,500 | 37,750 | ||
| 2022-07-15 | Afable Richard Director | Grant or award · Stock Option (Right to Buy) | +31,000 | 31,000 | ||
| 2022-07-15 | ADAMS ADRIAN Director | Grant or award | +15,500 | 211,750 | ||
| 2022-07-15 | ADAMS ADRIAN Director | Grant or award · Stock Option (Right to Buy) | +31,000 | 31,000 | ||
| 2022-07-15 | HOFFMAN STEPHEN J Director | Grant or award | +15,500 | 36,750 | ||
| 2022-07-15 | HOFFMAN STEPHEN J Director | Grant or award · Stock Option (Right to Buy) | +31,000 | 31,000 | ||
| 2022-07-15 | Rosen Howard B Director | Grant or award | +15,500 | 94,250 | ||
| 2022-07-15 | Rosen Howard B Director | Grant or award · Stock Option (Right to Buy) | +31,000 | 31,000 | ||
| 2022-07-15 | WAN MARK A Director | Grant or award | +15,500 | 36,750 | ||
| 2022-07-15 | WAN MARK A Director | Grant or award · Stock Option (Right to Buy) | +31,000 | 31,000 | ||
| 2022-06-07 | Angotti Vincent J. Chief Executive Officer | Purchase | +46,400 | $0.22 | $10K | 1,016,919 |
| 2022-03-03 | Palmer Pamela P Chief Medical Officer | Shares withheld for taxes | −7,923 | $0.41 | $3K | 779,261 |
| 2022-03-03 | Dasu Badri N Chief Engineering Officer | Shares withheld for taxes | −5,612 | $0.41 | $2K | 300,595 |
| 2022-03-03 | ASADORIAN RAFFI Chief Financial Officer | Shares withheld for taxes | −7,923 | $0.41 | $3K | 364,205 |
| 2022-03-03 | Angotti Vincent J. Chief Executive Officer | Shares withheld for taxes | −23,051 | $0.41 | $9K | 970,519 |
Page 9 of 9 · 179 trades